A VUS is a change in a gene that at this point in time is an unknown, meaning genetics professionals don't know if this change is harmful (i.e. disease causing) or benign. However, genetic counselors can play a critical role in helping individuals and families interpret VUS results and determine next steps for personal care.
At-home DNA tests have made a big splash about their ability to deliver medical information from the comfort of your own home. But, do these tests live up to the hype? Insight's lead genetic counselor Taya Fallen weighs in on the limitations and inaccuracies of direct-to-consumer genetic tests.
Over half of couples who seek treatment for infertility will go on to have healthy babies. As a part of that treatment, and when planning a pregnancy in general, it is recommended that all couples are offered genetic testing called carrier screening.
Today is officially dubbed by the National Human Genome Research Institute (NHGRI) as DNA Day, marking the anniversary of two genomic advances history: the discovery of the double-helical structure of DNA by Watson and Crick in 1953, and the completion of the Human Genome Project (HGP) by a collaboration of researchers in 2003. As a result of these scientific breakthroughs, we are currently living through a genomics revolution with life-changing medical advancements happening daily.
Public interest in high risk hereditary cancer conditions is on the rise. We’ve seen firsthand how increased awareness of hereditary breast and ovarian cancer has led to more individuals being identified with BRCA1 and BRCA2 gene mutations. Given that March is Colorectal Cancer Awareness Month, it might be time for another hereditary cancer syndrome to take some time in the spotlight. Enter center stage: Lynch syndrome.